ALK and pancreatic neoplasm: Interestingly, we found that among the 42 RTKs, Crizotinib inhibited the phosphorylation of ALK more than other tyrosine kinase receptors in both PANC-1 and MIA PaCa-2 pancreatic cancer cells.